====== ๐Ÿงพ Critical Review โ€” Folia Biologica (Prague) ====== **Journal**: ''Folia Biologica'' **Publisher**: First Faculty of Medicine, Charles University (Prague, Czech Republic) **ISSN**: 0015-5500 **Access**: Open Access (CC-BY) **Founded**: ~1955 **Website**: [[https://foliabiologica.lf1.cuni.cz|foliabiologica.lf1.cuni.cz]] ===== ๐Ÿ“š Indexing & Visibility ===== * Indexed in: Web of Science (SCIE), Scopus, PubMed/MedLine, EMBASE, DOAJ * Estimated h-index: ~36โ€“38 * Recognized in biomedical research and academic libraries ===== ๐Ÿ“ˆ Impact Metrics ===== ^ Metric ^ Value ^ Notes ^ | Clarivate Impact Factor (2023) | 1.1 | According to official site | | Scopus CiteScore | ~1.4 | Scopus database | | SJR (2024) | 0.229โ€“0.294 | Places it in Q4 for most categories | | Quartile Ranking | Q3โ€“Q4 | Varies by subject area | ===== โฑ๏ธ Peer Review & Publication Time ===== * Time to first decision: **~7 days** * Total review process: **~30 days** * External peer review claimed, though turnaround speed raises concerns about depth ===== ๐Ÿ’ถ Article Processing Charges (APC) ===== * Publication fee: **โ‚ฌ500** * Considered affordable compared to typical OA journals (โ‚ฌ1000โ€“3000) ===== โœ… Strengths ===== * Long-standing, non-predatory journal * Indexed in top biomedical databases * Open access under Creative Commons license * Rapid peer review and decision process * Relatively low publication fees ===== โŒ Limitations ===== * Modest impact factor and citation profile * Low international prestige * Speed may compromise rigorous review * Past isolated editorial conflict (e.g., retracted paper in 2010 due to authorship dispute) ===== ๐Ÿง  Reputation & Community Feedback ===== > "Not predatory, but low impact. Compared to not publishing, yes. But there are many more reputable journals." >> โ€” Reddit user on [[https://www.reddit.com/r/AskAcademia/comments/w0qbep/is_this_a_good_journal/|r/AskAcademia]] ===== ๐Ÿงญ Final Recommendation ===== **Folia Biologica** is a **legitimate and indexed open-access journal** with a long publishing history. It is best suited for: * Regional studies * Niche or exploratory biomedical research * Early-career researchers needing rapid, affordable publication Not recommended if: * Targeting high-impact journals * Prestige and citations are a priority * Journal quartile matters (e.g., for grants or tenure) **Bottom line**: Solid but modest. Use strategically.